Protean BioDiagnostics provides a complete framework for the development and commercialization of novel diagnostic services that support cancer diagnosis and treatment. Examples of key products include Oncology MAPS, a dynamic and adaptive system to assist community based oncologists access complete diagnostic lab services for their patients. They also offer RISK MAPS a whole exome genetic analysis solution, Liquid MAPS which covers bundles of novel blood tests for cancer patients to provide improved screening, diagnosis and monitoring. They operate a fully accredited CAP CLIA laboratory with full histology, pathology, digital pathology, image analysis, and molecular diagnostic solutions. Protean’s service line includes the development of new tests, design and implement of clinical trials and the reference lab services.
